AI in Medicine Digest – July 10, 2026
2026-07-10
- npj Digital Medicinean AI algorithm deployed across 14 Polish health systems screened 1.3M patients and lifted the rare-blood-disorder detection rate to 10.9% vs 6.9% conventional, cutting diagnostic delays of up to 3.7 years
- npj Digital Medicinea prospective LLM voice assistant completed 88% of 1,431 real pre-procedural cardiac-cath calls over 6 months, with system errors falling to 2.6%
- Sciencean autonomous general-purpose biomedical AI agent mines tools across 25 domains and generalizes across gene prioritization, drug repurposing and rare-disease diagnosis, but validation is benchmark and case-study only
- Naturea self-supervised foundation model builds a universal embedding of 36M cells across 8 species with zero-shot transfer, a research tool not a clinical one
AI in Medicine Digest – July 4, 2026
2026-07-04
- Nature Medicinea locally deployable, case-grounded LLM agent for hematology tumor-board decisions reaches 81.8% concordance on 555 external cases and 82.8% in a prospective 1-month silent trial (64 consecutive cases), with hallucinations in just 2/664 cases (0.3%)
- Nature Medicinea pan-cancer foundation model predicts immune-checkpoint-inhibitor response from bulk tumor transcriptomes, beating 22 methods across 16 retrospective cohorts spanning 7 cancers and 6 ICIs (accuracy +8.5%, AUPRC +15.7%), with responders showing longer overall survival (HR 4.7) — but validation remains retrospective/computational
AI in Medicine Digest – June 30, 2026
2026-06-30
- Naturedeep learning on a Swedish ECG-to-death registry flags a 2.2% high-risk group (7.0% annual SCD), 86% missed by LVEF, externally validated in the US and Taiwan
- Nature Medicinepragmatic cluster-RCT in 16 Kenyan primary-care clinics (n=9,691) finds LLM assistance safe but no reduction in treatment failure
- Nature Medicinemultimodal ML across 1,714 immunotherapy patients identifies a histidine-linked metabolic signature of response, with modest external validation
- Naturemembership-inference attacks re-identify individual patients near-perfectly and hit underrepresented groups hardest
- Nature MedicineGPT-5 and Gemini ace health benchmarks but fail under small perturbations, exposing a benchmark-vs-readiness gap